Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-003488

Co-Chief Executive Officer gave up 686 shares (to pay taxes)

  • Co-Chief Executive Officer acquired 1,562 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WEST MICHAEL D · Co-Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-01-10 Exercise or conversion : show line 1 in the form +1,562 885,401 D
2018-01-10 Shares withheld for taxes : show line 2 in the form −686 $2.68 $1,838 884,715 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-10 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,562 14,063 D
Loading xslF345X03/doc4.xml…